177 - Clinical Controversies

Friday, October 21, 2022

3:15 PM – 4:30 PM US ET

Location: 207 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Interactive Moderator(s)

Alice Kim, MD

Medical Director/Medical Operations, Staff Physician/Infectious Disease
Cleveland Clinic
Cleveland, OH, United States

Disclosure(s): No financial relationships to disclose

Slides
John Fangman, MD

Chief Medical Officer
Mass General Brigham Community Physicians , MA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Hannah Imlay, MD, MS

Assistant professor
Division of Infectious Diseases
University of Utah Health
Salt Lake City, UT, United States

Disclosure(s): No financial relationships to disclose
Olivia Kates, MD, MA

Assistant Professor
Johns Hopkins University

Disclosure(s): No financial relationships to disclose
Diane Havlir, MD

Professor of Medicine
University of California, San Francisco
San Francisco, CA, United States

Disclosure(s): No financial relationships to disclose
David Holland, MD, MHS, FIDSA

Associate Professor
Medical and Preventive Services; Division of Infectious Disease, School of Medicine
Emory University School of Medicine
Atlanta, GA, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Alice I. Kim, MD: No financial relationships to disclose

John JW Fangman, MD: No financial relationships to disclose

Hannah Imlay, MD, MS: No financial relationships to disclose

Olivia S. Kates, MD, MA: No financial relationships to disclose

Diane Havlir, MD: No financial relationships to disclose

David P. Holland, MD, MHS, FIDSA: No financial relationships to disclose

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit

No CPE Credit Offered

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss the ethical issues surrounding COVID-19 vaccine requirements for SOT candidates
describe the risk/benefit considerations of the use of ACAM2000 in potentially immune compromised recipients in an ongoing outbreak

Presentations:

3:15 PM – 3:50 PM US ET

Full COVID-19 Vaccination Should be Required for All Solid Organ Transplant Candidates: PRO/CON
Speaker: Hannah Imlay, MD, MS – University of Utah Health
Speaker: Olivia S. Kates, MD, MA – Johns Hopkins University
3:50 PM – 4:25 PM US ET

ACAM2000 Should Be a First-Line Vaccine in the Current Monkeypox Outbreak: Pro/Con
Speaker: David P. Holland, MD, MHS, FIDSA – Emory University School of Medicine
Speaker: Diane Havlir, MD – University of California, San Francisco